Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Cancer Res
    March 2026
  1. SWIFT SZ, Webster J, Mai H, Othoum G, et al
    Integration of Short- and Long-Read RNA Sequencing Enables the Discovery of Circular RNAs.
    Cancer Res. 2026;86:1300-1318.
    >> Share

    February 2026
  2. RONDEAU V, Bansal S, Buttigieg MM, Zeng AGX, et al
    Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.
    Cancer Res. 2026;86:845-857.
    >> Share

  3. SHI J, Wang X, Zhang W, Gao Z, et al
    AKT3-Driven Epithelial-Mesenchymal Plasticity Governs Ovarian Metastasis in Colorectal Cancer via Tumor Microenvironment Remodeling.
    Cancer Res. 2026 Feb 9. doi: 10.1158/0008-5472.CAN-25-1718.
    >> Share

  4. YUE Z, Dai W, Cao Z, Hu B, et al
    Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer.
    Cancer Res. 2026 Feb 9. doi: 10.1158/0008-5472.CAN-25-2586.
    >> Share

  5. BANERJEE M, Zaytseva YY, Reusch EM, Napier DL, et al
    FASN Inhibition Enhances the Efficacy of Chemotherapy in Colorectal Cancer by Inhibiting the DNA Damage Response.
    Cancer Res. 2026 Feb 9. doi: 10.1158/0008-5472.CAN-25-1917.
    >> Share

  6. LI Q, Zhang Z, Wang Y, Peng X, et al
    ARID1A Mediates SWI/SNF-Independent Maintenance of Heterochromatin Architecture to Restrain Viral Mimicry and Immunogenicity in Colon Cancer.
    Cancer Res. 2026 Feb 9. doi: 10.1158/0008-5472.CAN-25-3231.
    >> Share

  7. ZANI F, Blagih J
    Drink Responsibly: Cancer Cells Also Like Sugary Drinks.
    Cancer Res. 2026;86:569-570.
    >> Share

    January 2026
  8. YUAN Q, Sun Y, Zhang Y, Chen C, et al
    Intratumoral P. copri Reprograms MARCO+ Tumor-Associated Macrophages by Depleting Glycerophosphocholine to Drive Colorectal Cancer Progression.
    Cancer Res. 2026 Jan 27. doi: 10.1158/0008-5472.CAN-25-3400.
    >> Share

  9. KREGER BT, Liang Y, Reilly NM, Spears ME, et al
    CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.
    Cancer Res. 2026;86:438-452.
    >> Share

    December 2025
  10. DALAL PJ, Shah YM
    Gut Check: Lactobacillus johnsonii Harnesses Bile Acids and Reactive Oxygen Species to Suppress High-Fat Diet-Induced Colorectal Cancer.
    Cancer Res. 2025;85:4579-4581.
    >> Share

  11. ARNOUK SM, Kancheva D, Van Damme H, Courtoy GE, et al
    Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.
    Cancer Res. 2025;85:4681-4700.
    >> Share

  12. ZHAO J, Chen B, Deng Y, Fan L, et al
    ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion.
    Cancer Res. 2025;85:4701-4717.
    >> Share

    November 2025
  13. GILLETTE A, Udgata S, Schmitz AE, Stoecker JN, et al
    Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids.
    Cancer Res. 2025;85:4329-4340.
    >> Share

  14. MOHAMMAD MIRZAEI N, Hur C, Terry MB, Dalerba P, et al
    Modeling Early-Onset Cancer Kinetics Reveals Changes in Underlying Risk and the Impact of Population Screening.
    Cancer Res. 2025;85:4558-4570.
    >> Share

  15. NATTRESS CB, O'Sullivan R, Fowler D, Hutton C, et al
    Phenoscaping Reveals Multimodal gammadelta T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell-Mediated Immunomodulation.
    Cancer Res. 2025;85:4415-4432.
    >> Share

  16. FUMET JD, Latour C, Nuttin L, Derangere V, et al
    Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal Cancer.
    Cancer Res. 2025 Nov 6. doi: 10.1158/0008-5472.CAN-25-0079.
    >> Share

    October 2025
  17. BRUNET GUASCH M, Feeley NA, Soriano I, Thorn S, et al
    Mathematical Modeling Quantifies "Just-Right" APC Inactivation for Colorectal Cancer Initiation.
    Cancer Res. 2025 Oct 15. doi: 10.1158/0008-5472.CAN-25-0445.
    >> Share

  18. LI B, Li H, Li Y, Chen Z, et al
    Genetic Control of tRNA-Derived Fragments Contributes to Cancer Risk.
    Cancer Res. 2025;85:3855-3874.
    >> Share

  19. LIU S, Zhang Z, Wang Z, Liu C, et al
    SPP1 Drives Colorectal Cancer Liver Metastasis and Immunotherapy Resistance by Stimulating CXCL12 Production in Cancer-Associated Fibroblasts.
    Cancer Res. 2025 Oct 6. doi: 10.1158/0008-5472.CAN-24-4916.
    >> Share

  20. SCHATTON D, Frezza C
    Alternatively Spliced Citrate Synthase Supports Colorectal Cancer.
    Cancer Res. 2025 Oct 1:OF1-OF3. doi: 10.1158/0008-5472.CAN-25-3356.
    >> Share

    September 2025
  21. MODL B, Zwolanek D, Schwertner K, Krauss D, et al
    TYK2 Promotes Immunosurveillance of Colorectal Cancer Liver Metastasis.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-24-4224.
    >> Share

  22. ZHOU M, Liu H, Hui J, Chen Q, et al
    Extracellular Vesicle-Packaged miR-99a Reprograms Fibroblasts to Create an Inflammatory Niche that Drives Colorectal Cancer Metastasis.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-25-0663.
    >> Share

  23. SUN F, Wang K, Dong X, Secaira-Morocho H, et al
    The Microbial Bile Acid Metabolite 3-oxo-LCA Inhibits Colorectal Cancer Progression.
    Cancer Res. 2025 Sep 16. doi: 10.1158/0008-5472.CAN-24-3898.
    >> Share

  24. LIU C, Lai P, Hu J, Yin S, et al
    Lactobacillus johnsonii Synthesizes Chenodeoxycholic Acid to Reduce Susceptibility to High-Fat Diet-Induced Colorectal Cancer.
    Cancer Res. 2025 Sep 15. doi: 10.1158/0008-5472.CAN-25-0879.
    >> Share

  25. CHEUNG JCT, Ng LW, Zhu Z, Chen B, et al
    A Citrate Synthase Splice Variant Rewires the TCA Cycle to Promote Colorectal Cancer Progression.
    Cancer Res. 2025 Sep 3. doi: 10.1158/0008-5472.CAN-24-2355.
    >> Share

    August 2025
  26. ZHOU HM, Liu Y, Shi F, Qiu HW, et al
    CLK2 Regulates the KEAP1/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer.
    Cancer Res. 2025 Aug 29. doi: 10.1158/0008-5472.CAN-24-4949.
    >> Share

  27. ZHENG Z, Yuan F, Li J, Zhu X, et al
    Gut Microbiota-Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment.
    Cancer Res. 2025 Aug 27. doi: 10.1158/0008-5472.CAN-24-4425.
    >> Share

  28. SHORT SP
    Ferreting Out Ferroptosis: Extending the Mechanism of Action of RSL3 to the Selenoproteome in Colorectal Cancer.
    Cancer Res. 2025;85:2775-2777.
    >> Share

  29. OLIVEIRA EA, Milite S, Fernandez-Mateos J, Cresswell GD, et al
    Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm.
    Cancer Res. 2025;85:2921-2938.
    >> Share

    May 2025
  30. DEANGELO SL, Zhao L, Dziechciarz S, Shin M, et al
    Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer.
    Cancer Res. 2025 May 20. doi: 10.1158/0008-5472.CAN-24-3478.
    >> Share

  31. MATEJCIC M, Teer JK, Hoehn HJ, Diaz DB, et al
    Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles.
    Cancer Res. 2025;85:1928-1944.
    >> Share

  32. BUCKENMEYER MJ, Brooks EA, Taylor MS, Orenuga IK, et al
    A 3D Self-Assembly Platform Integrating Decellularized Matrix Recapitulates In Vivo Tumor Phenotypes and Heterogeneity.
    Cancer Res. 2025;85:1577-1595.
    >> Share

    March 2025
  33. TIKUM AF, Henning NW, Pougoue Ketchemen J, Doroudi A, et al
    An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Anti-Tumor Responses in KRAS and BRAF Mutant Colorectal Cancer.
    Cancer Res. 2025 Mar 24. doi: 10.1158/0008-5472.CAN-24-2266.
    >> Share

    February 2025
  34. LIN Y, Zhang Y, Huang T, Chen J, et al
    Arginine Deprivation Induces Quiescence and Confers Vulnerability to Ferroptosis in Colorectal Cancer.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-1940.
    >> Share

  35. DENG S, Wang J, Zou F, Cheng D, et al
    Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2892.
    >> Share

  36. XU J, Meng Q, Li X, Yang H, et al
    Correction: Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p.
    Cancer Res. 2025;85:826.
    >> Share

  37. CASTRO J, Daniels MH, Brennan D, Johnston B, et al
    A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch Repair.
    Cancer Res. 2025;85:758-776.
    >> Share

    January 2025
  38. LI D, Liu X, Gao W, Zhao W, et al
    An Immune Subtype Classification System Enables the Development of Strategies to Predict and Enhance Immunotherapy Responses in Colorectal Cancer.
    Cancer Res. 2025 Jan 29. doi: 10.1158/0008-5472.CAN-24-2464.
    >> Share

  39. KALLIO P, Bessone C, Seyednasrollah F, Brodkin J, et al
    A Multipotent PROX1+ Tumor Stem/Progenitor Cell Population Emerges During Intestinal Tumorigenesis and Mediates Radioresistance in Colorectal Cancer.
    Cancer Res. 2025 Jan 22. doi: 10.1158/0008-5472.CAN-23-1851.
    >> Share

    December 2024
  40. JACOB J, Anami Y, High PC, Liang Z, et al
    Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.
    Cancer Res. 2024 Dec 18. doi: 10.1158/0008-5472.CAN-24-0798.
    >> Share

  41. CUI L, Liu R, Han S, Zhang C, et al
    Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer.
    Cancer Res. 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-1611.
    >> Share

  42. GUO X, Luo S, Wang X, Cui Y, et al
    CD24-Targeted NIR-II Fluorescence Imaging Enables Early Detection of Colorectal Neoplasia.
    Cancer Res. 2024;84:4099-4113.
    >> Share

    October 2024
  43. CHUA J, Gregorieff A, Ayyaz A
    Bottom-up or Top-down: Inflammation Reprograms Paneth Cells to Develop Bowel Cancers.
    Cancer Res. 2024;84:3324-3326.
    >> Share

  44. LADAIKA CA, Ghobashi AH, Boulton WC, Miller SA, et al
    LSD1 and CoREST2 Potentiate STAT3 Activity to Promote Enteroendocrine Cell Differentiation in Mucinous Colorectal Cancer.
    Cancer Res. 2024 Oct 4. doi: 10.1158/0008-5472.CAN-24-0788.
    >> Share

  45. ROLFO C, Russo A
    The Next Frontier for Colorectal Cancer Screening: Blood-Based Tests.
    Cancer Res. 2024;84:3128-3129.
    >> Share

    September 2024
  46. WANG H, Chen J, Chen X, Liu Y, et al
    Cancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-Dependent Microenvironmental Remodeling to Support Colorectal Cancer.
    Cancer Res. 2024 Sep 9. doi: 10.1158/0008-5472.CAN-23-3987.
    >> Share

  47. CHEN D, Ji F, Zhou Q, Cheung H, et al
    RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.
    Cancer Res. 2024;84:2856-2872.
    >> Share

  48. SHU Y, Jin X, Ji M, Zhang Z, et al
    Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis.
    Cancer Res. 2024;84:2836-2855.
    >> Share

    August 2024
  49. SAHA S, Ghosh M, Li J, Wen A, et al
    Serine Depletion Promotes Antitumor Immunity by Activating Mitochondrial DNA-Mediated cGAS-STING Signaling.
    Cancer Res. 2024;84:2645-2659.
    >> Share

    July 2024
  50. CAO Y, Wang N, Wu X, Tang W, et al
    Multi-Dimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer.
    Cancer Res. 2024 Jul 29. doi: 10.1158/0008-5472.CAN-23-3486.
    >> Share

  51. LIAO S, Deng J, Deng M, Chen C, et al
    AFDN deficiency promotes liver tropism of metastatic colorectal cancer.
    Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3140.
    >> Share

    June 2024
  52. LI L, Jiang D, Liu H, Guo C, et al
    Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression.
    Cancer Res. 2024 Jun 11. doi: 10.1158/0008-5472.CAN-23-1878.
    >> Share

    May 2024
  53. BAKER AM, Nageswaran G, Nenclares P, Ronel T, et al
    FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA.
    Cancer Res. 2024;84:1560-1569.
    >> Share

  54. BAHRAMBEIGI V, Lee JJ, Branchi V, Rajapakshe KI, et al
    Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype.
    Cancer Res. 2024;84:1719-1732.
    >> Share

    April 2024
  55. YANG S, Zhang D, Sun Q, Nie H, et al
    Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.
    Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-23-3264.
    >> Share

  56. ZHAO N, Cao Y, Tao R, Zhu X, et al
    The circMYBL2-encoded p185 protein suppresses colorectal cancer progression by inhibiting serine biosynthesis.
    Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2940.
    >> Share

  57. CHEN Y, Ying Y, Ma W, Ma H, et al
    Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
    Cancer Res. 2024;84:1237-1251.
    >> Share

    March 2024
  58. MCCOLLUM SE, Shah YM
    Stressing Out Cancer: Chronic Stress Induces Dysbiosis and Enhances Colon Cancer Growth.
    Cancer Res. 2024;84:645-647.
    >> Share

  59. FANG L, Zhang L, Wang M, He Y, et al
    Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial-Mesenchymal Transition.
    Cancer Res. 2024;84:659-674.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016